{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:38:11Z","timestamp":1787002691891,"version":"build-2736575974"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,1,7]],"date-time":"2014-01-07T00:00:00Z","timestamp":1389052800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1038\/nrrheum.2013.205","type":"journal-article","created":{"date-parts":[[2014,1,7]],"date-time":"2014-01-07T07:03:23Z","timestamp":1389078203000},"page":"160-170","source":"Crossref","is-referenced-by-count":61,"title":["Of mice and men: how animal models advance our understanding of T-cell function in RA"],"prefix":"10.1038","volume":"10","author":[{"given":"Tam\u00e1s","family":"Kobezda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheida","family":"Ghassemi-Nejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Mikecz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tibor T.","family":"Glant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Szekanecz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,7]]},"reference":[{"key":"BFnrrheum2013205_CR1","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/ar3008","volume":"12","author":"T Kamradt","year":"2010","unstructured":"Kamradt, T. & Frey, O. Arthritis: where are the T cells? Arthritis Res. Ther. 12, 122 (2010).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum2013205_CR2","doi-asserted-by":"publisher","first-page":"R44","DOI":"10.1186\/ar2954","volume":"12","author":"A Angyal","year":"2010","unstructured":"Angyal, A. et al. Development of proteoglycan-induced arthritis depends on T cell-supported autoantibody production, but does not involve significant influx of T cells into the joints. Arthritis Res. Ther. 12, R44 (2010).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum2013205_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11926-001-0051-0","volume":"3","author":"Z Szekanecz","year":"2001","unstructured":"Szekanecz, Z. & Koch, A. E. Update on synovitis. Curr. Rheumatol. Rep. 3, 53\u201363 (2001).","journal-title":"Curr. Rheumatol. Rep."},{"key":"BFnrrheum2013205_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nrrheum.2012.149","volume":"9","author":"EJ Wehrens","year":"2013","unstructured":"Wehrens, E. J., Prakken, B. J. & van Wijk, F. T cells out of control\u2014impaired immune regulation in the inflamed joint. Nat. Rev. Rheumatol. 9, 34\u201342 (2013).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrrheum2013205_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/00002281-199106000-00013","volume":"3","author":"PH Wooley","year":"1991","unstructured":"Wooley, P. H. Animal models of rheumatoid arthritis. Curr. Opin. Rheumatol. 3, 407\u2013420 (1991).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrrheum2013205_CR6","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1016\/j.febslet.2011.04.034","volume":"585","author":"S Alzabin","year":"2011","unstructured":"Alzabin, S. & Williams, R. O. Effector T cells in rheumatoid arthritis: lessons from animal models. FEBS Lett. 585, 3649\u20133659 (2011).","journal-title":"FEBS Lett."},{"key":"BFnrrheum2013205_CR7","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/art.1780300211","volume":"30","author":"TT Glant","year":"1987","unstructured":"Glant, T. T., Mikecz, K., Arzoumanian, A. & Poole, A. R. Proteoglycan-induced arthritis in BALB\/c mice. Clinical features and histopathology. Arthritis Rheum. 30, 201\u2013212 (1987).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2013205_CR8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1615\/CritRevImmunol.v23.i3.20","volume":"23","author":"TT Glant","year":"2003","unstructured":"Glant, T. T., Finnegan, A. & Mikecz, K. Proteoglycan-induced arthritis: immune regulation, cellular mechanisms, and genetics. Crit. Rev. Immunol. 23, 199\u2013250 (2003).","journal-title":"Crit. Rev. Immunol."},{"key":"BFnrrheum2013205_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.imlet.2013.03.005","volume":"152","author":"P Misjak","year":"2013","unstructured":"Misjak, P. et al. The role of citrullination of an immunodominant proteoglycan (PG) aggrecan T cell epitope in BALB\/c mice with PG-induced arthritis. Immunol. Lett. 152, 25\u201331 (2013).","journal-title":"Immunol. Lett."},{"issue":"Suppl. 3","key":"BFnrrheum2013205_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/ar811","volume":"5","author":"S Sakaguchi","year":"2003","unstructured":"Sakaguchi, S., Takahashi, T., Hata, T., Nomura, T. & Sakaguchi, N. SKG mice, a new genetic model of rheumatoid arthritis. Arthritis Res. Ther. 5 (Suppl. 3), 10 (2003).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum2013205_CR11","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/0008-8749(92)90250-S","volume":"144","author":"S Banerjee","year":"1992","unstructured":"Banerjee, S., Webber, C. & Poole, A. R. The induction of arthritis in mice by the cartilage proteoglycan aggrecan: roles of CD4+ and CD8+ T cells. Cell. Immunol. 144, 347\u2013357 (1992).","journal-title":"Cell. Immunol."},{"key":"BFnrrheum2013205_CR12","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0171-2985(11)80593-0","volume":"184","author":"TJ Goldschmidt","year":"1992","unstructured":"Goldschmidt, T. J., Andersson, M., Malmstrom, V. & Holmdahl, R. Activated type II collagen reactive T cells are not eliminated by in vivo anti-CD4 treatment. Implications for therapeutic approaches on autoimmune arthritis. Immunobiology 184, 359\u2013371 (1992).","journal-title":"Immunobiology"},{"key":"BFnrrheum2013205_CR13","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/j.1365-2249.1994.tb06070.x","volume":"97","author":"KM Kadowaki","year":"1994","unstructured":"Kadowaki, K. M., Matsuno, H., Tsuji, H. & Tunru, I. CD4+ T cells from collagen-induced arthritic mice are essential to transfer arthritis into severe combined immunodeficient mice. Clin. Exp. Immunol. 97, 212\u2013218 (1994).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnrrheum2013205_CR14","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.4049\/jimmunol.172.7.4503","volume":"172","author":"D Schubert","year":"2004","unstructured":"Schubert, D., Maier, B., Morawietz, L., Krenn, V. & Kamradt, T. Immunization with glucose-6-phosphate isomerase induces T cell-dependent peripheral polyarthritis in genetically unaltered mice. J. Immunol. 172, 4503\u20134509 (2004).","journal-title":"J. Immunol."},{"key":"BFnrrheum2013205_CR15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/ar2446","volume":"10","author":"R Thomas","year":"2008","unstructured":"Thomas, R., Turner, M. & Cope, A. P. High avidity autoreactive T cells with a low signalling capacity through the T-cell receptor: central to rheumatoid arthritis pathogenesis? Arthritis Res. Ther. 10, 210 (2008).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum2013205_CR16","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/ar1185","volume":"6","author":"AP Cope","year":"2004","unstructured":"Cope, A. P. Altered signalling thresholds in T lymphocytes cause autoimmune arthritis. Arthritis Res. Ther. 6, 112\u2013116 (2004).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum2013205_CR17","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1002\/art.34459","volume":"64","author":"O Snir","year":"2012","unstructured":"Snir, O. et al. Multifunctional T cell reactivity with native and glycosylated type II collagen in rheumatoid arthritis. Arthritis Rheum. 64, 2482\u20132488 (2012).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2013205_CR18","doi-asserted-by":"publisher","first-page":"R118","DOI":"10.1186\/ar3848","volume":"14","author":"SC Law","year":"2012","unstructured":"Law, S. C. et al. T-cell autoreactivity to citrullinated autoantigenic peptides in rheumatoid arthritis patients carrying HLA-DRB1 shared epitope alleles. Arthritis Res. Ther. 14, R118 (2012).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum2013205_CR19","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1002\/art.1780301102","volume":"30","author":"PK Gregersen","year":"1987","unstructured":"Gregersen, P. K., Silver, J. & Winchester, R. J. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 30, 1205\u20131213 (1987).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2013205_CR20","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s12016-012-8346-7","volume":"45","author":"J Kurko","year":"2013","unstructured":"Kurko, J. et al. Genetics of rheumatoid arthritis\u2014a comprehensive review. Clin. Rev. Allergy Immunol. 45, 170\u2013179 (2013).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"BFnrrheum2013205_CR21","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.4049\/jimmunol.157.11.5178","volume":"157","author":"DD Brand","year":"1996","unstructured":"Brand, D. D. et al. Autoantibodies to murine type II collagen in collagen-induced arthritis: a comparison of susceptible and nonsusceptible strains. J. Immunol. 157, 5178\u20135184 (1996).","journal-title":"J. Immunol."},{"key":"BFnrrheum2013205_CR22","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S1074-7613(00)80045-X","volume":"10","author":"AS Korganow","year":"1999","unstructured":"Korganow, A. S. et al. From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity 10, 451\u2013461 (1999).","journal-title":"Immunity"},{"key":"BFnrrheum2013205_CR23","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S0092-8674(00)81989-3","volume":"87","author":"V Kouskoff","year":"1996","unstructured":"Kouskoff, V. et al. Organ-specific disease provoked by systemic autoimmunity. Cell 87, 811\u2013822 (1996).","journal-title":"Cell"},{"key":"BFnrrheum2013205_CR24","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/1529-0131(200103)44:3<561::AID-ANR104>3.0.CO;2-Z","volume":"44","author":"SH Park","year":"2001","unstructured":"Park, S. H. et al. Shift toward T helper 1 cytokines by type II collagen-reactive T cells in patients with rheumatoid arthritis. Arthritis Rheum. 44, 561\u2013569 (2001).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2013205_CR25","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/art.25064","volume":"62","author":"A von Delwig","year":"2010","unstructured":"von Delwig, A., Locke, J., Robinson, J. H. & Ng, W. F. Response of TH17 cells to a citrullinated arthritogenic aggrecan peptide in patients with rheumatoid arthritis. Arthritis Rheum. 62, 143\u2013149 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2013205_CR26","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.4049\/jimmunol.166.6.4177","volume":"166","author":"C Masson-Bessiere","year":"2001","unstructured":"Masson-Bessiere, C. et al. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the \u03b1- and \u03b2-chains of fibrin. J. Immunol. 166, 4177\u20134184 (2001).","journal-title":"J. Immunol."},{"key":"BFnrrheum2013205_CR27","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.4049\/jimmunol.1201517","volume":"190","author":"KN Cordova","year":"2013","unstructured":"Cordova, K. N., Willis, V. C., Haskins, K. & Holers, V. M. A citrullinated fibrinogen-specific T cell line enhances autoimmune arthritis in a mouse model of rheumatoid arthritis. J. Immunol. 190, 1457\u20131465 (2013).","journal-title":"J. Immunol."},{"key":"BFnrrheum2013205_CR28","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/art.1780390606","volume":"39","author":"I Waase","year":"1996","unstructured":"Waase, I., Kayser, C., Carlson, P. J., Goronzy, J. J. & Weyand, C. M. Oligoclonal T cell proliferation in patients with rheumatoid arthritis and their unaffected siblings. Arthritis Rheum. 39, 904\u2013913 (1996).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2013205_CR29","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.4049\/jimmunol.161.2.1018","volume":"161","author":"M Schirmer","year":"1998","unstructured":"Schirmer, M., Vallejo, A. N., Weyand, C. M. & Goronzy, J. J. Resistance to apoptosis and elevated expression of BCL-2 in clonally expanded CD4+CD28\u2212 T cells from rheumatoid arthritis patients. J. Immunol. 161, 1018\u20131025 (1998).","journal-title":"J. Immunol."},{"key":"BFnrrheum2013205_CR30","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1002\/art.1780401203","volume":"40","author":"P Miossec","year":"1997","unstructured":"Miossec, P. & van den Berg, W. TH1\/TH2 cytokine balance in arthritis. Arthritis Rheum. 40, 2105\u20132115 (1997).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2013205_CR31","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3109\/08916939409009532","volume":"18","author":"M De Carli","year":"1994","unstructured":"De Carli, M., D'Elios, M. M., Zancuoghi, G., Romagnani, S. & Del Prete, G. Human TH1 and TH2 cells: functional properties, regulation of development and role in autoimmunity. Autoimmunity 18, 301\u2013308 (1994).","journal-title":"Autoimmunity"},{"key":"BFnrrheum2013205_CR32","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/ni0907-903","volume":"8","author":"A Laurence","year":"2007","unstructured":"Laurence, A. & O'Shea, J. J. TH17 differentiation: of mice and men. Nat. Immunol. 8, 903\u2013905 (2007).","journal-title":"Nat. Immunol."},{"key":"BFnrrheum2013205_CR33","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nrrheum.2009.179","volume":"5","author":"WB van den Berg","year":"2009","unstructured":"van den Berg, W. B. & Miossec, P. IL-17 as a future therapeutic target for rheumatoid arthritis. Nat. Rev. Rheumatol. 5, 549\u2013553 (2009).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrrheum2013205_CR34","doi-asserted-by":"publisher","first-page":"92","DOI":"10.4049\/jimmunol.1000960","volume":"186","author":"PC Janson","year":"2011","unstructured":"Janson, P. C. et al. Profiling of CD4+ T cells with epigenetic immune lineage analysis. J. Immunol. 186, 92\u2013102 (2011).","journal-title":"J. Immunol."},{"key":"BFnrrheum2013205_CR35","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.4049\/jimmunol.163.10.5383","volume":"163","author":"A Finnegan","year":"1999","unstructured":"Finnegan, A., Mikecz, K., Tao, P. & Glant, T. T. Proteoglycan (aggrecan)-induced arthritis in BALB\/c mice is a TH1-type disease regulated by TH2 cytokines. J. Immunol. 163, 5383\u20135390 (1999).","journal-title":"J. Immunol."},{"key":"BFnrrheum2013205_CR36","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/ar383","volume":"4","author":"C Kaplan","year":"2002","unstructured":"Kaplan, C. et al. TH1 and TH2 cytokines regulate proteoglycan-specific autoantibody isotypes and arthritis. Arthritis Res. 4, 54\u201358 (2002).","journal-title":"Arthritis Res."},{"key":"BFnrrheum2013205_CR37","doi-asserted-by":"publisher","first-page":"4900","DOI":"10.4049\/jimmunol.1101844","volume":"187","author":"KM Hamel","year":"2011","unstructured":"Hamel, K. M. et al. B cell depletion enhances T regulatory cell activity essential in the suppression of arthritis. J. Immunol. 187, 4900\u20134906 (2011).","journal-title":"J. Immunol."},{"key":"BFnrrheum2013205_CR38","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1002\/art.20180","volume":"50","author":"A Hanyecz","year":"2004","unstructured":"Hanyecz, A. et al. Achievement of a synergistic adjuvant effect on arthritis induction by activation of innate immunity and forcing the immune response toward the TH1 phenotype. Arthritis Rheum. 50, 1665\u20131676 (2004).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2013205_CR39","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/art.23291","volume":"58","author":"K Nistala","year":"2008","unstructured":"Nistala, K. et al. Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers. Arthritis Rheum. 58, 875\u2013887 (2008).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2013205_CR40","doi-asserted-by":"publisher","first-page":"14751","DOI":"10.1073\/pnas.1003852107","volume":"107","author":"K Nistala","year":"2010","unstructured":"Nistala, K. et al. TH17 plasticity in human autoimmune arthritis is driven by the inflammatory environment. Proc. Natl Acad. Sci. USA 107, 14751\u201314756 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrrheum2013205_CR41","doi-asserted-by":"publisher","first-page":"6173","DOI":"10.4049\/jimmunol.171.11.6173","volume":"171","author":"S Nakae","year":"2003","unstructured":"Nakae, S., Nambu, A., Sudo, K. & Iwakura, Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. 171, 6173\u20136177 (2003).","journal-title":"J. Immunol."},{"key":"BFnrrheum2013205_CR42","doi-asserted-by":"publisher","first-page":"329","DOI":"10.4049\/jimmunol.181.1.329","volume":"181","author":"PD Doodes","year":"2008","unstructured":"Doodes, P. D. et al. Development of proteoglycan-induced arthritis is independent of IL-17. J. Immunol. 181, 329\u2013337 (2008).","journal-title":"J. Immunol."},{"key":"BFnrrheum2013205_CR43","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/imm.12019","volume":"138","author":"JN Stoop","year":"2012","unstructured":"Stoop, J. N., Tibbitt, C. A., van Eden, W., Robinson, J. H. & Hilkens, C. M. The choice of adjuvant determines the cytokine profile of T cells in proteoglycan-induced arthritis but does not influence disease severity. Immunology 138, 68\u201375 (2012).","journal-title":"Immunology"},{"key":"BFnrrheum2013205_CR44","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.immuni.2011.12.013","volume":"36","author":"V Santarlasci","year":"2012","unstructured":"Santarlasci, V. et al. Rarity of human T helper 17 cells is due to retinoic acid orphan receptor-dependent mechanisms that limit their expansion. Immunity 36, 201\u2013214 (2012).","journal-title":"Immunity"},{"key":"BFnrrheum2013205_CR45","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.immuni.2010.04.016","volume":"32","author":"R Mukasa","year":"2010","unstructured":"Mukasa, R. et al. Epigenetic instability of cytokine and transcription factor gene loci underlies plasticity of the T helper 17 cell lineage. Immunity 32, 616\u2013627 (2010).","journal-title":"Immunity"},{"key":"BFnrrheum2013205_CR46","doi-asserted-by":"publisher","first-page":"5615","DOI":"10.4049\/jimmunol.1101058","volume":"187","author":"CJ Cohen","year":"2011","unstructured":"Cohen, C. J. et al. Human TH1 and TH17 cells exhibit epigenetic stability at signature cytokine and transcription factor loci. J. Immunol. 187, 5615\u20135626 (2011).","journal-title":"J. Immunol."},{"key":"BFnrrheum2013205_CR47","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.immuni.2008.11.005","volume":"30","author":"YK Lee","year":"2009","unstructured":"Lee, Y. K. et al. Late developmental plasticity in the T helper 17 lineage. Immunity 30, 92\u2013107 (2009).","journal-title":"Immunity"},{"key":"BFnrrheum2013205_CR48","doi-asserted-by":"publisher","first-page":"948218","DOI":"10.1155\/2012\/948218","volume":"2012","author":"A Chakera","year":"2012","unstructured":"Chakera, A. et al. The phenotype of circulating follicular-helper T cells in patients with rheumatoid arthritis defines CD200 as a potential therapeutic target. Clin. Dev. Immunol. 2012, 948218 (2012).","journal-title":"Clin. Dev. Immunol."},{"key":"BFnrrheum2013205_CR49","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1749-6632.2003.tb06042.x","volume":"987","author":"CM Weyand","year":"2003","unstructured":"Weyand, C. M. & Goronzy, J. J. Ectopic germinal center formation in rheumatoid synovitis. Ann. NY Acad. Sci. 987, 140\u2013149 (2003).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnrrheum2013205_CR50","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.it.2010.07.001","volume":"31","author":"D Yu","year":"2010","unstructured":"Yu, D. & Vinuesa, C. G. The elusive identity of T follicular helper cells. Trends Immunol. 31, 377\u2013383 (2010).","journal-title":"Trends Immunol."},{"key":"BFnrrheum2013205_CR51","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.coi.2013.03.003","volume":"25","author":"AO Kamphorst","year":"2013","unstructured":"Kamphorst, A. O. & Ahmed, R. Manipulating the PD-1 pathway to improve immunity. Curr. Opin. Immunol. 25, 381\u2013388 (2013).","journal-title":"Curr. Opin. Immunol."},{"key":"BFnrrheum2013205_CR52","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1084\/jem.20081886","volume":"206","author":"MA Linterman","year":"2009","unstructured":"Linterman, M. A. et al. Follicular helper T cells are required for systemic autoimmunity. J. Exp. Med. 206, 561\u2013576 (2009).","journal-title":"J. Exp. Med."},{"key":"BFnrrheum2013205_CR53","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.immuni.2010.12.012","volume":"34","author":"R Morita","year":"2011","unstructured":"Morita, R. et al. Human blood CXCR5+CD4+ T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 34, 108\u2013121 (2011).","journal-title":"Immunity"},{"key":"BFnrrheum2013205_CR54","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1002\/art.27500","volume":"62","author":"AP Raptopoulou","year":"2010","unstructured":"Raptopoulou, A. P. et al. The programmed death 1\/programmed death ligand 1 inhibitory pathway is up-regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritis. Arthritis Rheum. 62, 1870\u20131880 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2013205_CR55","doi-asserted-by":"publisher","first-page":"8844","DOI":"10.4049\/jimmunol.177.12.8844","volume":"177","author":"B Wan","year":"2006","unstructured":"Wan, B. et al. Aberrant regulation of synovial T cell activation by soluble costimulatory molecules in rheumatoid arthritis. J. Immunol. 177, 8844\u20138850 (2006).","journal-title":"J. Immunol."},{"key":"BFnrrheum2013205_CR56","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1002\/eji.201040690","volume":"40","author":"KM Hamel","year":"2010","unstructured":"Hamel, K. M. et al. B7-H1 expression on non-B and non-T cells promotes distinct effects on T- and B-cell responses in autoimmune arthritis. Eur J. Immunol. 40, 3117\u20133127 (2010).","journal-title":"Eur J. Immunol."},{"key":"BFnrrheum2013205_CR57","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.immuni.2011.11.012","volume":"35","author":"S Nakayamada","year":"2012","unstructured":"Nakayamada, S. et al. Early TH1 cell differentiation is marked by a TFH cell-like transition. Immunity 35, 919\u2013931 (2012).","journal-title":"Immunity"},{"key":"BFnrrheum2013205_CR58","first-page":"116","volume":"6","author":"X Lin","year":"2013","unstructured":"Lin, X. et al. Advances in distinguishing natural from induced FOXP3+ regulatory T cells. Int. J. Clin. Exp. Pathol. 6, 116\u2013123 (2013).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"BFnrrheum2013205_CR59","doi-asserted-by":"publisher","first-page":"19396","DOI":"10.1073\/pnas.0806855105","volume":"105","author":"F Flores-Borja","year":"2008","unstructured":"Flores-Borja, F., Jury, E. C., Mauri, C. & Ehrenstein, M. R. Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis. Proc. Natl Acad. Sci. USA 105, 19396\u201319401 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrrheum2013205_CR60","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1084\/jem.20061531","volume":"204","author":"S Nadkarni","year":"2007","unstructured":"Nadkarni, S., Mauri, C. & Ehrenstein, M. R. Anti-TNF-\u03b1 therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-\u03b2. J. Exp. Med. 204, 33\u201339 (2007).","journal-title":"J. Exp. Med."},{"key":"BFnrrheum2013205_CR61","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.drudis.2007.05.002","volume":"12","author":"J Bayry","year":"2007","unstructured":"Bayry, J., Siberil, S., Triebel, F., Tough, D. F. & Kaveri, S. V. Rescuing CD4+CD25+ regulatory T-cell functions in rheumatoid arthritis by cytokine-targeted monoclonal antibody therapy. Drug Discov. Today 12, 548\u2013552 (2007).","journal-title":"Drug Discov. Today"},{"key":"BFnrrheum2013205_CR62","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1002\/art.34565","volume":"64","author":"JL McGovern","year":"2012","unstructured":"McGovern, J. L. et al. TH17 cells are restrained by TREG cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy. Arthritis Rheum. 64, 3129\u20133138 (2012).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2013205_CR63","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1002\/art.21195","volume":"52","author":"ME Morgan","year":"2005","unstructured":"Morgan, M. E. et al. Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum. 52, 2212\u20132221 (2005).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2013205_CR64","doi-asserted-by":"publisher","first-page":"5233","DOI":"10.1182\/blood-2007-12-128488","volume":"111","author":"ST Roord","year":"2008","unstructured":"Roord, S. T. et al. Autologous bone marrow transplantation in autoimmune arthritis restores immune homeostasis through CD4+CD25+FOXP3+ regulatory T cells. Blood 111, 5233\u20135241 (2008).","journal-title":"Blood"},{"key":"BFnrrheum2013205_CR65","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/art.22272","volume":"56","author":"LT Nguyen","year":"2007","unstructured":"Nguyen, L. T., Jacobs, J., Mathis, D. & Benoist, C. Where FOXP3-dependent regulatory T cells impinge on the development of inflammatory arthritis. Arthritis Rheum. 56, 509\u2013520 (2007).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2013205_CR66","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.1365-2249.2009.04037.x","volume":"159","author":"SQ Crome","year":"2010","unstructured":"Crome, S. Q., Wang, A. Y. & Levings, M. K. Translational mini-review series on TH17 cells: function and regulation of human T helper 17 cells in health and disease. Clin. Exp. Immunol. 159, 109\u2013119 (2010).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnrrheum2013205_CR67","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1365-2249.2009.04038.x","volume":"159","author":"B Afzali","year":"2010","unstructured":"Afzali, B., Mitchell, P., Lechler, R. I., John, S. & Lombardi, G. Translational mini-review series on TH17 cells: induction of interleukin-17 production by regulatory T cells. Clin. Exp. Immunol. 159, 120\u2013130 (2010).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnrrheum2013205_CR68","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1365-2249.2009.04040.x","volume":"159","author":"RA O'Connor","year":"2010","unstructured":"O'Connor, R. A., Taams, L. S. & Anderton, S. M. Translational mini-review series on TH17 cells: CD4 T helper cells: functional plasticity and differential sensitivity to regulatory T cell-mediated regulation. Clin. Exp. Immunol. 159, 137\u2013147 (2010).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnrrheum2013205_CR69","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1182\/blood-2005-11-4567","volume":"108","author":"X Valencia","year":"2006","unstructured":"Valencia, X. et al. TNF downmodulates the function of human CD4+CD25hi T-regulatory cells. Blood 108, 253\u2013261 (2006).","journal-title":"Blood"},{"key":"BFnrrheum2013205_CR70","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nm.3085","volume":"19","author":"H Nie","year":"2013","unstructured":"Nie, H. et al. Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-\u03b1 in rheumatoid arthritis. Nat. Med. 19, 322\u2013328 (2013).","journal-title":"Nat. Med."},{"key":"BFnrrheum2013205_CR71","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1084\/jem.20040165","volume":"200","author":"MR Ehrenstein","year":"2004","unstructured":"Ehrenstein, M. R. et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNF\u03b1 therapy. J. Exp. Med. 200, 277\u2013285 (2004).","journal-title":"J. Exp. Med."},{"key":"BFnrrheum2013205_CR72","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/art.27203","volume":"62","author":"HL Ma","year":"2010","unstructured":"Ma, H. L. et al. Tumor necrosis factor \u03b1 blockade exacerbates murine psoriasis-like disease by enhancing TH17 function and decreasing expansion of TREG cells. Arthritis Rheum. 62, 430\u2013440 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2013205_CR73","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1002\/eji.201041004","volume":"41","author":"J Herrath","year":"2011","unstructured":"Herrath, J. et al. The inflammatory milieu in the rheumatic joint reduces regulatory T-cell function. Eur. J. Immunol. 41, 2279\u20132290 (2011).","journal-title":"Eur. J. Immunol."},{"key":"BFnrrheum2013205_CR74","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1182\/blood-2008-01-133967","volume":"112","author":"HJ Koenen","year":"2008","unstructured":"Koenen, H. J. et al. Human CD25highFOXP3pos regulatory T cells differentiate into IL-17-producing cells. Blood 112, 2340\u20132352 (2008).","journal-title":"Blood"},{"key":"BFnrrheum2013205_CR75","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1002\/art.20499","volume":"50","author":"JM van Amelsfort","year":"2004","unstructured":"van Amelsfort, J. M., Jacobs, K. M., Bijlsma, J. W., Lafeber, F. P. & Taams, L. S. CD4+CD25+ regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum. 50, 2775\u20132785 (2004).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2013205_CR76","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1002\/art.21532","volume":"52","author":"I Gal","year":"2005","unstructured":"Gal, I. et al. Visualization and in situ analysis of leukocyte trafficking into the ankle joint in a systemic murine model of rheumatoid arthritis. Arthritis Rheum. 52, 3269\u20133278 (2005).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2013205_CR77","doi-asserted-by":"publisher","first-page":"7037","DOI":"10.4049\/jimmunol.173.11.7037","volume":"173","author":"P Svendsen","year":"2004","unstructured":"Svendsen, P. et al. Tracking of proinflammatory collagen-specific T cells in early and late collagen-induced arthritis in humanized mice. J. Immunol. 173, 7037\u20137045 (2004).","journal-title":"J. Immunol."},{"key":"BFnrrheum2013205_CR78","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2741\/s53","volume":"2","author":"Z Szekanecz","year":"2010","unstructured":"Szekanecz, Z., Vegvari, A., Szabo, Z. & Koch, A. E. Chemokines and chemokine receptors in arthritis. Front. Biosci. (Schol. Ed.) 2, 153\u2013167 (2010).","journal-title":"Front. Biosci. (Schol. Ed.)"},{"key":"BFnrrheum2013205_CR79","first-page":"356","volume":"69","author":"Z Szekanecz","year":"2011","unstructured":"Szekanecz, Z., Koch, A. E. & Tak, P. P. Chemokine and chemokine receptor blockade in arthritis, a prototype of immune-mediated inflammatory diseases. Neth. J. Med. 69, 356\u2013366 (2011).","journal-title":"Neth. J. Med."},{"key":"BFnrrheum2013205_CR80","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1084\/jem.20071397","volume":"204","author":"K Hirota","year":"2007","unstructured":"Hirota, K. et al. Preferential recruitment of CCR6-expressing TH17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J. Exp. Med. 204, 2803\u20132812 (2007).","journal-title":"J. Exp. Med."},{"key":"BFnrrheum2013205_CR81","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/34814","volume":"391","author":"P Loetscher","year":"1998","unstructured":"Loetscher, P. et al. CCR5 is characteristic of TH1 lymphocytes. Nature 391, 344\u2013345 (1998).","journal-title":"Nature"},{"key":"BFnrrheum2013205_CR82","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1172\/JCI1422","volume":"101","author":"S Qin","year":"1998","unstructured":"Qin, S. et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J. Clin. Invest. 101, 746\u2013754 (1998).","journal-title":"J. Clin. Invest."},{"key":"BFnrrheum2013205_CR83","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/j.1365-2249.2007.03377.x","volume":"148","author":"A Aggarwal","year":"2007","unstructured":"Aggarwal, A., Agarwal, S. & Misra, R. Chemokine and chemokine receptor analysis reveals elevated interferon-inducible protein-10 (IP)-10\/CXCL10 levels and increased number of CCR5+ and CXCR3+ CD4 T cells in synovial fluid of patients with enthesitis-related arthritis (ERA). Clin. Exp. Immunol. 148, 515\u2013519 (2007).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnrrheum2013205_CR84","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1046\/j.1365-2249.2001.01542.x","volume":"125","author":"T Matsui","year":"2001","unstructured":"Matsui, T. et al. Selective recruitment of CCR6-expressing cells by increased production of MIP-3\u03b1 in rheumatoid arthritis. Clin. Exp. Immunol. 125, 155\u2013161 (2001).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnrrheum2013205_CR85","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1093\/rheumatology\/keq224","volume":"49","author":"NE Aerts","year":"2010","unstructured":"Aerts, N. E. et al. Increased IL-17 production by peripheral T helper cells after tumour necrosis factor blockade in rheumatoid arthritis is accompanied by inhibition of migration-associated chemokine receptor expression. Rheumatology (Oxford) 49, 2264\u20132272 (2010).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum2013205_CR86","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cellimm.2012.08.003","volume":"278","author":"T Kobezda","year":"2012","unstructured":"Kobezda, T., Ghassemi-Nejad, S., Glant, T. T. & Mikecz, K. In vivo two-photon imaging of T cell motility in joint-draining lymph nodes in a mouse model of rheumatoid arthritis. Cell. Immunol. 278, 158\u2013165 (2012).","journal-title":"Cell. Immunol."},{"key":"BFnrrheum2013205_CR87","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12016-007-8022-5","volume":"34","author":"Z Szekanecz","year":"2008","unstructured":"Szekanecz, Z. et al. Anti-citrullinated protein antibodies in rheumatoid arthritis: as good as it gets? Clin. Rev. Allergy Immunol. 34, 26\u201331 (2008).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"BFnrrheum2013205_CR88","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1136\/ard.2008.100677","volume":"69","author":"V Nell-Duxneuner","year":"2010","unstructured":"Nell-Duxneuner, V. et al. Autoantibody profiling in patients with very early rheumatoid arthritis\u2014a follow-up study. Ann. Rheum. Dis. 69, 169\u2013174 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2013205_CR89","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/BOR.0b013e3282fbd22a","volume":"20","author":"L Klareskog","year":"2008","unstructured":"Klareskog, L., Widhe, M., Hermansson, M. & Ronnelid, J. Antibodies to citrullinated proteins in arthritis: pathology and promise. Curr. Opin. Rheumatol. 20, 300\u2013305 (2008).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrrheum2013205_CR90","first-page":"253","volume":"26","author":"G Lakos","year":"2008","unstructured":"Lakos, G. et al. Anti-cyclic citrullinated peptide antibody isotypes in rheumatoid arthritis: association with disease duration, rheumatoid factor production and the presence of shared epitope. Clin. Exp. Rheumatol. 26, 253\u2013260 (2008).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrrheum2013205_CR91","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1002\/1529-0131(200110)44:10<2255::AID-ART388>3.0.CO;2-#","volume":"44","author":"D Baeten","year":"2001","unstructured":"Baeten, D. et al. Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: relevance to antifilaggrin autoantibodies. Arthritis Rheum. 44, 2255\u20132262 (2001).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2013205_CR92","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/rheumatology\/keh414","volume":"44","author":"X Chang","year":"2005","unstructured":"Chang, X. et al. Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis. Rheumatology (Oxford) 44, 40\u201350 (2005).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum2013205_CR93","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/art.21691","volume":"55","author":"D Caspi","year":"2006","unstructured":"Caspi, D. et al. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis. Arthritis Rheum. 55, 53\u201356 (2006).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2013205_CR94","doi-asserted-by":"publisher","first-page":"e35296","DOI":"10.1371\/journal.pone.0035296","volume":"7","author":"J Sokolove","year":"2012","unstructured":"Sokolove, J. et al. Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS ONE 7, e35296 (2012).","journal-title":"PLoS ONE"},{"key":"BFnrrheum2013205_CR95","doi-asserted-by":"publisher","first-page":"929","DOI":"10.3899\/jrheum.111315","volume":"39","author":"BA Fisher","year":"2012","unstructured":"Fisher, B. A. et al. Heterogeneity of anticitrullinated peptide antibodies and response to anti-tumor necrosis factor agents in rheumatoid arthritis. J. Rheumatol. 39, 929\u2013932 (2012).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum2013205_CR96","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1002\/art.23936","volume":"58","author":"K Lundberg","year":"2008","unstructured":"Lundberg, K. et al. Antibodies to citrullinated \u03b1-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis Rheum. 58, 3009\u20133019 (2008).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2013205_CR97","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1002\/art.24635","volume":"60","author":"T Cantaert","year":"2009","unstructured":"Cantaert, T. et al. Alterations of the synovial T cell repertoire in anti-citrullinated protein antibody-positive rheumatoid arthritis. Arthritis Rheum. 60, 1944\u20131956 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2013205_CR98","doi-asserted-by":"publisher","first-page":"R119","DOI":"10.1186\/ar2523","volume":"10","author":"BA Kidd","year":"2008","unstructured":"Kidd, B. A. et al. Epitope spreading to citrullinated antigens in mouse models of autoimmune arthritis and demyelination. Arthritis Res. Ther. 10, R119 (2008).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum2013205_CR99","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1002\/art.30261","volume":"63","author":"TT Glant","year":"2011","unstructured":"Glant, T. T. et al. Proteoglycan-induced arthritis and recombinant human proteoglycan aggrecan G1 domain-induced arthritis in BALB\/c mice resembling two subtypes of rheumatoid arthritis. Arthritis Rheum. 63, 1312\u20131321 (2011).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2013205_CR100","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1136\/ard.2007.084277","volume":"67","author":"K Raza","year":"2008","unstructured":"Raza, K., Mullazehi, M., Salmon, M., Buckley, C. D. & Ronnelid, J. Anti-collagen type II antibodies in patients with very early synovitis. Ann. Rheum. Dis. 67, 1354\u20131355 (2008).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2013205_CR101","doi-asserted-by":"publisher","first-page":"4658","DOI":"10.1073\/pnas.1001074107","volume":"107","author":"H Huang","year":"2010","unstructured":"Huang, H., Benoist, C. & Mathis, D. Rituximab specifically depletes short-lived autoreactive plasma cells in a mouse model of inflammatory arthritis. Proc. Natl Acad. Sci. USA 107, 4658\u20134663 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrrheum2013205_CR102","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/art.1780330614","volume":"33","author":"K Mikecz","year":"1990","unstructured":"Mikecz, K., Glant, T. T., Buzas, E. & Poole, A. R. Proteoglycan-induced polyarthritis and spondylitis adoptively transferred to naive (nonimmunized) BALB\/c mice. Arthritis Rheum. 33, 866\u2013876 (1990).","journal-title":"Arthritis Rheum."},{"issue":"Suppl. 2","key":"BFnrrheum2013205_CR103","doi-asserted-by":"publisher","first-page":"ii43","DOI":"10.1136\/ard.61.suppl_2.ii43","volume":"61","author":"E Keystone","year":"2002","unstructured":"Keystone, E. Treatments no longer in development for rheumatoid arthritis. Ann. Rheum. Dis. 61 (Suppl. 2), ii43\u2013ii45 (2002).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2013205_CR104","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1056\/NEJMoa050524","volume":"353","author":"MC Genovese","year":"2005","unstructured":"Genovese, M. C. et al. Abatacept for rheumatoid arthritis refractory to tumor necrosis factor \u03b1 inhibition. N. Engl. J. Med. 353, 1114\u20131123 (2005).","journal-title":"N. Engl. J. Med."},{"key":"BFnrrheum2013205_CR105","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.clim.2008.01.011","volume":"127","author":"SN Liossis","year":"2008","unstructured":"Liossis, S. N. & Sfikakis, P. P. Rituximab-induced B cell depletion in autoimmune diseases: potential effects on T cells. Clin. Immunol. 127, 280\u2013285 (2008).","journal-title":"Clin. Immunol."},{"key":"BFnrrheum2013205_CR106","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2174\/1874312900802010081","volume":"2","author":"M Feuchtenberger","year":"2008","unstructured":"Feuchtenberger, M. et al. Frequency of regulatory T cells is not affected by transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis. Open Rheumatol. J. 2, 81\u201388 (2008).","journal-title":"Open Rheumatol. J."},{"key":"BFnrrheum2013205_CR107","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.1002\/art.24998","volume":"60","author":"E Wilk","year":"2009","unstructured":"Wilk, E. et al. Depletion of functionally active CD20+ T cells by rituximab treatment. Arthritis Rheum. 60, 3563\u20133571 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2013205_CR108","doi-asserted-by":"publisher","first-page":"3572","DOI":"10.1002\/art.24978","volume":"60","author":"CE Vergunst","year":"2009","unstructured":"Vergunst, C. E. et al. MLN3897 plus methotrexate in patients with rheumatoid arthritis: safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double-blind, placebo-controlled, randomized, proof-of-concept study. Arthritis Rheum. 60, 3572\u20133581 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2013205_CR109","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1002\/art.34494","volume":"64","author":"C Egelston","year":"2012","unstructured":"Egelston, C. et al. Suppression of dendritic cell maturation and t cell proliferation by synovial fluid myeloid cells from mice with autoimmune arthritis. Arthritis Rheum. 64, 3179\u20133188 (2012).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2013205_CR110","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1002\/art.30469","volume":"63","author":"RJ Marijnissen","year":"2011","unstructured":"Marijnissen, R. J. et al. Increased expression of interleukin-22 by synovial TH17 cells during late stages of murine experimental arthritis is controlled by interleukin-1 and enhances bone degradation. Arthritis Rheum. 63, 2939\u20132948 (2011).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2013205_CR111","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.humimm.2010.01.010","volume":"71","author":"X Niu","year":"2010","unstructured":"Niu, X. et al. IL-21 regulates TH17 cells in rheumatoid arthritis. Hum. Immunol. 71, 334\u2013341 (2010).","journal-title":"Hum. Immunol."},{"key":"BFnrrheum2013205_CR112","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/00002281-200305000-00012","volume":"15","author":"EC Keystone","year":"2003","unstructured":"Keystone, E. C. Abandoned therapies and unpublished trials in rheumatoid arthritis. Curr. Opin. Rheumatol. 15, 253\u2013258 (2003).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrrheum2013205_CR113","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/BOR.0b013e3283457524","volume":"23","author":"R de Vries","year":"2011","unstructured":"de Vries, R. Genetics of rheumatoid arthritis: time for a change! Curr. Opin. Rheumatol. 23, 227\u2013232 (2011).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrrheum2013205_CR114","doi-asserted-by":"publisher","first-page":"284751","DOI":"10.1155\/2012\/284751","volume":"2012","author":"T Besenyei","year":"2012","unstructured":"Besenyei, T. et al. Non-MHC risk alleles in rheumatoid arthritis and in the syntenic chromosome regions of corresponding animal models. Clin. Dev. Immunol. 2012, 284751 (2012).","journal-title":"Clin. Dev. Immunol."},{"key":"BFnrrheum2013205_CR115","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature07021","volume":"454","author":"L Yang","year":"2008","unstructured":"Yang, L. et al. IL-21 and TGF-\u03b2 are required for differentiation of human TH17 cells. Nature 454, 350\u2013352 (2008).","journal-title":"Nature"},{"key":"BFnrrheum2013205_CR116","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ajpath.2012.03.044","volume":"181","author":"MS Maddur","year":"2012","unstructured":"Maddur, M. S., Miossec, P., Kaveri, S. V. & Bayry, J. TH17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am. J. Pathol. 181, 8\u201318 (2012).","journal-title":"Am. J. Pathol."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2013.205.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2013.205","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2013.205.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T12:38:24Z","timestamp":1716381504000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrrheum.2013.205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,7]]},"references-count":116,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["BFnrrheum2013205"],"URL":"https:\/\/doi.org\/10.1038\/nrrheum.2013.205","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,7]]}}}